Baxter recalls two lots of 0.9% Sodium Chloride Injection over possible fiberglass particles
Baxter International announced a voluntary recall of two batches of its 0.9% Sodium Chloride Injection after detecting potential fiberglass particles in the solution.
The company said the particulate matter could cause serious health issues if administered intravenously, including vessel blockage, pulmonary embolism, and organ damage.
No adverse events have been reported to date, and Baxter is working with the FDA to remove the affected lots from the market.
The recalled product is used as a source of water and electrolytes and for priming hemodialysis equipment.
This writeup was produced by pharmadog from original reporting by fda medwatch.
Original headline: “Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter”
read at fda medwatch ↗
comments(0)
5-min edit window · permanent after that